肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ELN建议：慢性髓性白血病的治疗

2020-03-03 欧洲白血病网 Leukemia. 2020 Mar 3.

慢性髓性白血病

2020年3月，欧洲白血病网(ELN)发布了慢性髓性白血病的治疗建议，在过去的7年间，慢性髓性白血病（CML）的治疗发生了很大变化。欧洲白血病网(ELN)组织相关专家商定了新的慢性髓性白血病的治疗建议

中文标题：

2020 ELN建议：慢性髓性白血病的治疗

英文标题：

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

发布机构：

欧洲白血病网

发布日期：

2020-03-03

简要介绍：

2020年3月，欧洲白血病网(ELN)发布了慢性髓性白血病的治疗建议，在过去的7年间，慢性髓性白血病（CML）的治疗发生了很大变化。欧洲白血病网(ELN)组织相关专家商定了新的慢性髓性白血病的治疗建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=2291c1c0018e72ec, title=2020 ELN建议：慢性髓性白血病的治疗, enTitle=European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia., guiderFrom=Leukemia. 2020 Mar 3., authorId=0, author=, summary=2020年3月，欧洲白血病网(ELN)发布了慢性髓性白血病的治疗建议，在过去的7年间，慢性髓性白血病（CML）的治疗发生了很大变化。欧洲白血病网(ELN)组织相关专家商定了新的慢性髓性白血病的治疗建议, cover=https://img.medsci.cn/2020312/1583943712610_2020535.jpg, journalId=0, articlesId=null, associationId=148, associationName=欧洲白血病网, associationIntro=欧洲白血病网由欧盟资助，包含白血病相关的医生，科学家和白血病患者。其旨在提高欧洲白血病的治疗及知识传播，促进医生及患者教育。, copyright=0, guiderPublishedTime=Tue Mar 03 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年3月，欧洲白血病网(ELN)发布了慢性髓性白血病的治疗建议，在过去的7年间，慢性髓性白血病（CML）的治疗发生了很大变化。欧洲白血病网(ELN)组织相关专家商定了新的慢性髓性白血病的治疗建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=4900, tagName=慢性髓性白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4900, guiderKeyword=慢性髓性白血病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3675, appHits=108, showAppHits=8, pcHits=1729, showPcHits=3481, likes=0, shares=3, comments=6, approvalStatus=1, publishedTime=Thu Mar 12 00:49:02 CST 2020, publishedTimeString=2020-03-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 12 00:21:57 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 04:03:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066187, encodeId=fb32106618e26, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:22 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056565, encodeId=c2c5105656526, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:36:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901911, encodeId=684890191106, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:43 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901910, encodeId=295390191056, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:37 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-11-02 denglimoxiaoran

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066187, encodeId=fb32106618e26, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:22 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056565, encodeId=c2c5105656526, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:36:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901911, encodeId=684890191106, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:43 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901910, encodeId=295390191056, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:37 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-09-30 13f0c37dm61暂无昵称

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066187, encodeId=fb32106618e26, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:22 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056565, encodeId=c2c5105656526, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:36:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901911, encodeId=684890191106, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:43 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901910, encodeId=295390191056, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:37 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2020-11-24 wxt0426

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1066187, encodeId=fb32106618e26, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:22 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056565, encodeId=c2c5105656526, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:36:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901911, encodeId=684890191106, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:43 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901910, encodeId=295390191056, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:22:37 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2020-11-24 wxt0426

    谢谢

    0

相关指南

2016 中国慢性髓性白血病诊断与治疗指南

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2016-09-07

拓展阅读

2016 中国慢性髓性白血病诊断与治疗指南

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2016-09-07

慢性髓性白血病中国诊断与治疗指南（2020年版）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2020-05-15

2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-4.慢性髓性白血病/骨髓增殖性肿瘤

日本血液学会(JSH,Japanese Society of Hematology) · 2020-08-11

慢性髓性白血病诊疗指南 （2022年版）

中华人民共和国国家卫生健康委员会 · 2022-04-11

2023 国际儿童CML专家组建议：儿童和青少年慢性髓性白血病急变期的治疗

国际BFM研究组(I-BFM SG,International BFM Study Group) · 2023-01-27

2023 多学科共识：慢性髓性白血病心血管风险的筛查和管理

国外血液科相关专家小组 · 2023-04-25